According to a published report in the Wall St. Journal, Glaxo Smith Kline became the latest drug manufacturer to add a warning label to its ADHD drug, Dexedrine. The new warning label will include a warning about cardiac risks and psychiatric side effects. The new warning was posted on the FDA website yesterday.
Glaxo Smith Kline Adds Warning to Drug
According to a published report in the Wall St. Journal, Glaxo Smith Kline became the latest drug manufacturer to add a warning label to its ADHD drug, Dexedrine. The new warning label will include a warning about cardiac risks and psychiatric side effects. The new warning was posted on the FDA webs
Tags:
Health
More in Health
See all
